| 注册
首页|期刊导航|中医学报|基于"分子-证候"双维度探讨不同亚型小细胞肺癌的中医精准辨治思路

基于"分子-证候"双维度探讨不同亚型小细胞肺癌的中医精准辨治思路

李姝蒙 张甘霖 李慧 成琳 吴静红 马腾 杨国旺

中医学报2026,Vol.41Issue(5):915-921,7.
中医学报2026,Vol.41Issue(5):915-921,7.DOI:10.16368/j.issn.1674-8999.2026.05.134

基于"分子-证候"双维度探讨不同亚型小细胞肺癌的中医精准辨治思路

Precise TCM Diagnosis and Treatment Approaches for Different Subtypes of Small Cell Lung Cancer in"Molecular-Syndrome"Dual Dimensions

李姝蒙 1张甘霖 2李慧 2成琳 2吴静红 3马腾 3杨国旺2

作者信息

  • 1. 首都医科大学,北京 100010||首都医科大学附属北京中医医院肿瘤科,北京 100010
  • 2. 首都医科大学附属北京中医医院肿瘤科,北京 100010
  • 3. 首都医科大学附属北京胸科医院,北京 101125
  • 折叠

摘要

Abstract

Small cell lung cancer(SCLC)is a highly aggressive neuroendocrine tumor.Currently,the most common subtype classifica-tion of SCLC is mainly based on transcription factors,defined as SCLC-A,SCLC-N,SCLC-P,SCLC-I,and other subtypes.This pa-per systematically constructs,for the first time,the mapping relationship between SCLC molecular subtypes and traditional Chinese med-icine(TCM)syndromes and proposes"molecular-syndrome co-evolution"hypothesis.A precise medication scheme of"syndrome recognition-syndrome differentiation-compound formula"is designed,organically combining SCLC molecular subtyping with TCM syndrome differentiation and treatment.This can,to some extent,overcome the limitations of traditional treatment and provide a new par-adigm for individualized precision therapy.At the same time,it can reveal the biological basis of TCM syndromes at the molecular level(for example,the association of the SCLC-I subtype with the immune microenvironment of"Yin deficiency with internal Heat,defi-ciency of the body's Zheng Qi with lingering Evil Factors"syndrome),breaking through the bottleneck of TCM theory's"abstract-ness".Although this theoretical framework requires further basic research and clinical validation,its integrative thinking is expected to provide certain reference value for tumor treatment.In the future,it is necessary to establish a dynamic correlation model between molec-ular subtypes and TCM syndromes,develop a standardized efficacy evaluation system,and conduct multicenter clinical studies to verify the feasibility of the"molecular-syndrome co-evolution"model based on the dual dimensions of"molecule-syndrome".

关键词

小细胞肺癌/分子分型/中医辨证/精准诊疗/分子/证候/辨病/辨型/辨证

Key words

small cell lung cancer/molecular subtyping/TCM syndrome differentiation/precision diagnosis and treatment/molecular/syndrome/disease differentiation/type differentiation/syndrome differentiation

分类

医药卫生

引用本文复制引用

李姝蒙,张甘霖,李慧,成琳,吴静红,马腾,杨国旺..基于"分子-证候"双维度探讨不同亚型小细胞肺癌的中医精准辨治思路[J].中医学报,2026,41(5):915-921,7.

基金项目

国家重点研发计划项目(2018YFC1705101) (2018YFC1705101)

中医学报

1674-8999

访问量0
|
下载量0
段落导航相关论文